πŸ‡ΊπŸ‡Έ FDA
Patent

US 11174262

Compounds, compositions and methods

granted A61PA61P25/16A61P25/28

Quick answer

US patent 11174262 (Compounds, compositions and methods) held by DENALI THERAPEUTICS INC. expires Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DENALI THERAPEUTICS INC.
Grant date
Tue Nov 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P25/16, A61P25/28